Intell11, i`m defending anyone here, just want to put the facts straight. According to asx release from 30/05/11 STI did not paid 100 000 to immune network, but issued shares instead.
"The Agreement is conditional upon Immune Network becoming current in its statutory filings, following which Immune Network will issue to Stirling 20 million shares for the non- exclusive marketing rights to ImmunoXel and providing Stirling with direct exposure to potential profitability from Immune Network's other TB immunotherapy, V-5 Immunitor. Further Stirling will subscribe to 5 million Immune shares at US$0.02 per share with such subscription to be satisfied by the issue of 12.5 million Stirling shares and 333,333 Zodiac shares. The Agreement also resolves the differences recently reported following the development of the new sublingual tablet form of ImmunoXel by Immune Network Limited."
STI Price at posting:
0.2¢ Sentiment: None Disclosure: Held
